nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—ADRB1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0261	0.0261	CbGpPWpGaD
Bevantolol—ADRB2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0255	0.0255	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Other—P2RY11—narcolepsy	0.0238	0.0238	CbGpPWpGaD
Bevantolol—ADRA1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.0211	0.0211	CbGpPWpGaD
Bevantolol—ADRA1A—AMPK Signaling—CPT1B—narcolepsy	0.0197	0.0197	CbGpPWpGaD
Bevantolol—ADRB1—G alpha (s) signalling events—P2RY11—narcolepsy	0.019	0.019	CbGpPWpGaD
Bevantolol—ADRB2—G alpha (s) signalling events—P2RY11—narcolepsy	0.0186	0.0186	CbGpPWpGaD
Bevantolol—ADRB1—Monoamine GPCRs—HTR2A—narcolepsy	0.0155	0.0155	CbGpPWpGaD
Bevantolol—ADRB2—Monoamine GPCRs—HTR2A—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Bevantolol—ADRB1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.013	0.013	CbGpPWpGaD
Bevantolol—ADRB2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0127	0.0127	CbGpPWpGaD
Bevantolol—ADRA1A—Monoamine GPCRs—HTR2A—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Bevantolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.011	0.011	CbGpPWpGaD
Bevantolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.011	0.011	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Bevantolol—ADRB1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0106	0.0106	CbGpPWpGaD
Bevantolol—ADRA1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0104	0.0104	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00991	0.00991	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—HCRT—narcolepsy	0.00942	0.00942	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00939	0.00939	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00939	0.00939	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00919	0.00919	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00919	0.00919	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00907	0.00907	CbGpPWpGaD
Bevantolol—ADRB1—G alpha (s) signalling events—NPS—narcolepsy	0.00891	0.00891	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00887	0.00887	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00887	0.00887	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00887	0.00887	CbGpPWpGaD
Bevantolol—ADRB2—G alpha (s) signalling events—NPS—narcolepsy	0.00872	0.00872	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00857	0.00857	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00843	0.00843	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00771	0.00771	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0076	0.0076	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0076	0.0076	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00755	0.00755	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00734	0.00734	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—HCRTR2—narcolepsy	0.00715	0.00715	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—HCRTR1—narcolepsy	0.00715	0.00715	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.00714	0.00714	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—HCRTR1—narcolepsy	0.007	0.007	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—HCRTR2—narcolepsy	0.007	0.007	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—P2RY11—narcolepsy	0.00691	0.00691	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00688	0.00688	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—P2RY11—narcolepsy	0.00676	0.00676	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00673	0.00673	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Other—HTR2A—narcolepsy	0.00672	0.00672	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00639	0.00639	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00624	0.00624	CbGpPWpGaD
Bevantolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00598	0.00598	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.00587	0.00587	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00585	0.00585	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00585	0.00585	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00579	0.00579	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00579	0.00579	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.00575	0.00575	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00572	0.00572	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.00559	0.00559	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.00524	0.00524	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00519	0.00519	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00519	0.00519	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00513	0.00513	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.00512	0.00512	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00501	0.00501	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.00475	0.00475	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00473	0.00473	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00464	0.00464	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00464	0.00464	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.00435	0.00435	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00425	0.00425	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00425	0.00425	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00424	0.00424	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00415	0.00415	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00404	0.00404	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00404	0.00404	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00395	0.00395	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00395	0.00395	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.0039	0.0039	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.0039	0.0039	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.00367	0.00367	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.00367	0.00367	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.0036	0.0036	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.00359	0.00359	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.00359	0.00359	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.00355	0.00355	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00344	0.00344	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00344	0.00344	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00327	0.00327	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00327	0.00327	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.00325	0.00325	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.00301	0.00301	CbGpPWpGaD
Bevantolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00298	0.00298	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00292	0.00292	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.00289	0.00289	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00256	0.00256	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—TRH—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	0.00221	0.00221	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.00212	0.00212	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.00212	0.00212	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—P2RY11—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—P2RY11—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HRH3—narcolepsy	0.002	0.002	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HRH3—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—NPS—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—NPS—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HCRT—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HCRT—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—TAC1—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—NPS—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—NPS—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—TAC1—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PENK—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PENK—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TRH—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TRH—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HRH3—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HRH3—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	0.000999	0.000999	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TAC1—narcolepsy	0.000981	0.000981	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NPS—narcolepsy	0.000981	0.000981	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	0.000977	0.000977	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TAC1—narcolepsy	0.000959	0.000959	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NPS—narcolepsy	0.000959	0.000959	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000958	0.000958	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.00089	0.00089	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.000808	0.000808	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000793	0.000793	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000793	0.000793	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HTR2A—narcolepsy	0.00059	0.00059	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HTR2A—narcolepsy	0.000577	0.000577	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000477	0.000477	CbGpPWpGaD
